Skip to main content
OricPharma logo
About
Overview
Leadership Team
Board of Directors
Founders
Contact
Pipeline
Overview
Rinzimetostat
(ORIC-944)
Enozertinib
(ORIC-114)
Publications
Patients
Overview
Clinical Trials
Investors & News
Overview
Press Releases
Events & Presentations
Stock Information
Analyst Coverage
Corporate Governance
SEC Filings
Investor FAQs
Contact
Careers
Overview
Culture & Values
Benefits
Current Openings
CONTACT US
info@oricpharma.com
(650) 388-5600
1
1
pipeline
The owner of this website has made a commitment to accessibility and inclusion, please report any problems that you encounter using the contact form on this website. This site uses the WP ADA Compliance Check plugin to enhance accessibility.